Financhill
Buy
79

RIGL Quote, Financials, Valuation and Earnings

Last price:
$44.57
Seasonality move :
-1.35%
Day range:
$43.23 - $44.71
52-week range:
$14.63 - $52.24
Dividend yield:
0%
P/E ratio:
7.13x
P/S ratio:
2.86x
P/B ratio:
6.78x
Volume:
274.8K
Avg. volume:
610.1K
1-year change:
156.21%
Market cap:
$797.6M
Revenue:
$179.3M
EPS (TTM):
$6.17

Earnings Data

Next earnings date for RIGL
Mar 03
2026
Most recent earnings per share
$1.46
Beat by $0.52
(Nov 4/2025)
Consensus Estimate
$0.94
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RIGL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/03/2026 Q4 $66.4M -- -- $1.10 --
11/04/2025 Q3 $61.9M $69.5M $1.46 $0.94 $0.52
08/05/2025 Q2 $72.6M $101.7M $3.28 $1.41 $1.88
05/06/2025 Q1 $43.9M $53.3M $0.63 $0.09 $0.54
03/04/2025 Q4 $57.6M $57.6M $0.80 $0.58 $0.22
11/07/2024 Q3 $41.9M $55.3M $0.70 $0.06 $0.64
08/06/2024 Q2 $33.7M $36.8M -$0.06 -$0.18 $0.12
05/07/2024 Q1 $31.5M $29.5M -$0.47 -$0.27 -$0.21
03/05/2024 Q4 $33.4M $35.8M $0.04 -$0.24 $0.28
11/07/2023 Q3 -- $28.1M -$0.33 -- --
08/01/2023 Q2 -- $26.9M -$0.38 -- --
05/02/2023 Q1 -- $26.1M -$0.78 -- --
03/07/2023 Q4 -- $51.3M $0.08 -- --
11/03/2022 Q3 -- $22.4M -$1.10 -- --
08/02/2022 Q2 -- $29.8M -$0.78 -- --
05/03/2022 Q1 -- $16.7M -$1.60 -- --
03/01/2022 Q4 -- $20.4M -$1.32 -- --
11/02/2021 Q3 -- $21.5M -$1.23 -- --
08/03/2021 Q2 -- $26.3M -$0.81 -- --
05/05/2021 Q1 -- $81M $2.24 -- --
03/02/2021 Q4 -- $18.5M -$1.14 -- --
11/05/2020 Q3 -- $18.4M -$0.84 -- --
08/04/2020 Q2 -- $16M -$1.04 -- --
05/05/2020 Q1 -- $55.8M $1.26 -- --
02/27/2020 Q4 -- $15.4M -$1.03 -- --
11/05/2019 Q3 -- $20.9M -$0.69 -- --
08/06/2019 Q2 -- $10.4M -$1.23 -- --
05/07/2019 Q1 -- $12.6M -$1.05 -- --
02/28/2019 Q4 -- $37.9M $0.19 -- --
11/06/2018 Q3 -- $4.9M -$1.43 -- --
08/08/2018 Q2 -- $1.8M -$1.60 -- --
05/01/2018 Q1 -- -- -$1.70 -- --
03/06/2018 Q4 -- -- -$1.80 -- --
11/01/2017 Q3 -- $900K -$1.40 -- --
08/01/2017 Q2 -- -- -$1.60 -- --
04/25/2017 Q1 -- $3.6M -$1.30 -- --
03/07/2017 Q4 -- $3M -$1.60 -- --
11/01/2016 Q3 -- $3.8M -$2.40 -- --
08/02/2016 Q2 -- $8.6M -$1.50 -- --
05/03/2016 Q1 -- $5M -$1.90 -- --
03/08/2016 Q4 -- $8.5M -$1.40 -- --

Rigel Pharmaceuticals, Inc. Earnings Questions

  • How Much did Rigel Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Rigel Pharmaceuticals, Inc. reported $69.5M worth of top line sales in its most recent quarter.

  • Did Rigel Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Rigel Pharmaceuticals, Inc. announced earnings per share of $1.46 which represents a beat of analyst forecast a $0.94 per share.

  • Is Rigel Pharmaceuticals, Inc. Profitable?

    Rigel Pharmaceuticals, Inc. reported $64.7M that represents $3.38 per share over the last quarter.

  • What is the Analyst Consensus for Rigel Pharmaceuticals, Inc. EPS Next Year?

    Rigel Pharmaceuticals, Inc.'s earnings are forecast to grow from $0.99 per share to $0.41 per share next year representing an increase of 562.12%.

  • When is Rigel Pharmaceuticals, Inc.'s Earnings Date?

    Rigel Pharmaceuticals, Inc.'s next earnings date is March 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock